In this episode of The Story Behind the AP Story, we hear from Lauran Neergaard and Shelby Lum, who have been following the ...

We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands ...

United Therapeutics Corporation (Nasdaq ... We have fun, we do good. We are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation (PBC).

TORONTO - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL), a clinical-stage life sciences company with a market capitalization of approximately $78 million, has reported significant progress in ...

Based on these findings, Cardiol Therapeutics is proceeding with the Phase III MAVERIC trial, which aims to enroll 110 patients in the United States ... cause of heart failure and sudden cardiac ...

Aardvark bolstered its cash runway through the successful completion ... small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, today reported ...

We recently published a list of 20 Most Expensive Stocks Insiders Are Dumping In March. In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands ...

Find out in our full research report, it’s free. Founded by a mother seeking treatment for her daughter's pulmonary arterial hypertension, United Therapeutics (NASDAQ:UTHR) develops and ...

A pig with a similar level of genetic modification served as the heart donor for the historical first pig-to-human clinical xenotransplantation performed ... The second trial, sponsored by United ...

This compares with -$22.27 million, or -$1.71 per share, last year. Gain Therapeutics Inc earnings at a glance (GAAP) : -Earnings: -$20.41 Mln. vs. -$22.27 Mln. last year. -EPS: -$0.89 vs.